APA
Kumar R., Bunn P. T., Singh S. S., Ng S. S., Montes de Oca M., De Labastida Rivera F., Chauhan S. B., Singh N., Faleiro R. J., Edwards C. L., Frame T. C. M., Sheel M., Austin R. J., Lane S. W., Bald T., Smyth M. J., Hill G. R., Best S. E., Haque A., Corvino D., Waddell N., Koufariotis L., Mukhopadhay P., Rai M., Chakravarty J., Singh O. P., Sacks D., Nylen S., Uzonna J., Sundar S. & Engwerda C. R. (20210317). Type I Interferons Suppress Anti-parasitic Immunity and Can Be Targeted to Improve Treatment of Visceral Leishmaniasis. : Cell reports.
Chicago
Kumar Rajiv, Bunn Patrick T, Singh Siddharth Sankar, Ng Susanna S, Montes de Oca Marcela, De Labastida Rivera Fabian, Chauhan Shashi Bhushan, Singh Neetu, Faleiro Rebecca J, Edwards Chelsea L, Frame Teija C M, Sheel Meru, Austin Rebecca J, Lane Steven W, Bald Tobias, Smyth Mark J, Hill Geoffrey R, Best Shannon E, Haque Ashraful, Corvino Dillon, Waddell Nic, Koufariotis Lambross, Mukhopadhay Pamela, Rai Madhukar, Chakravarty Jaya, Singh Om Prakash, Sacks David, Nylen Susanne, Uzonna Jude, Sundar Shyam and Engwerda Christian R. 20210317. Type I Interferons Suppress Anti-parasitic Immunity and Can Be Targeted to Improve Treatment of Visceral Leishmaniasis. : Cell reports.
Harvard
Kumar R., Bunn P. T., Singh S. S., Ng S. S., Montes de Oca M., De Labastida Rivera F., Chauhan S. B., Singh N., Faleiro R. J., Edwards C. L., Frame T. C. M., Sheel M., Austin R. J., Lane S. W., Bald T., Smyth M. J., Hill G. R., Best S. E., Haque A., Corvino D., Waddell N., Koufariotis L., Mukhopadhay P., Rai M., Chakravarty J., Singh O. P., Sacks D., Nylen S., Uzonna J., Sundar S. and Engwerda C. R. (20210317). Type I Interferons Suppress Anti-parasitic Immunity and Can Be Targeted to Improve Treatment of Visceral Leishmaniasis. : Cell reports.
MLA
Kumar Rajiv, Bunn Patrick T, Singh Siddharth Sankar, Ng Susanna S, Montes de Oca Marcela, De Labastida Rivera Fabian, Chauhan Shashi Bhushan, Singh Neetu, Faleiro Rebecca J, Edwards Chelsea L, Frame Teija C M, Sheel Meru, Austin Rebecca J, Lane Steven W, Bald Tobias, Smyth Mark J, Hill Geoffrey R, Best Shannon E, Haque Ashraful, Corvino Dillon, Waddell Nic, Koufariotis Lambross, Mukhopadhay Pamela, Rai Madhukar, Chakravarty Jaya, Singh Om Prakash, Sacks David, Nylen Susanne, Uzonna Jude, Sundar Shyam and Engwerda Christian R. Type I Interferons Suppress Anti-parasitic Immunity and Can Be Targeted to Improve Treatment of Visceral Leishmaniasis. : Cell reports. 20210317.